InvestorsHub Logo
Followers 33
Posts 2859
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Tuesday, 10/01/2019 6:22:42 PM

Tuesday, October 01, 2019 6:22:42 PM

Post# of 262
SITC titles: (P173) Case reports: Correlates of response following adoptive transfer of ADP-A2M4, affinity-enhanced T-cells targeting MAGE-A4, in synovial sarcoma https://sitc.sitcancer.org/2019/abstracts/titles/index.php?filter=Cellular+Therapies

(P423) SURPASS trial design: A phase 1 dose escalation trial to assess safety and efficacy of ADP-A2M4CD8 in HLA-A2+ patients with MAGE-A4+ tumors https://sitc.sitcancer.org/2019/abstracts/titles/index.php?filter=Clinical+Trial+In+Progress
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News